Chugai and Biofourmis Collaborating to Develop Digital Solution For Objective Assessment of Pain

By
Sam Draper
-
Chugai Biofourmis partnership
Biofourmis’ Biovitals platform collects and interprets vast amounts of population metadata and compares it to real-time patient physiological signals to provide a clearer picture of chronic patients and their disease trajectory (Image: Biofourmis)
Chugai Pharmaceutical, one of Japan’s leading research-based pharmaceutical companies and Biofourmis, a Boston-based digital therapeutics company, announced that they have partnered to develop a digital solution for the objective assessment […]
To access this page, watch the live streams and videos on-demand, please register free of charge to the WT | Wearable Technologies COMMUNITY.
Previous articleMIT Researchers Develop New Method of Stimulating Neurons
Next articleNoninvasive Wearable Sensors to Advance Chronic Respiratory Disease Management In Patients Around the World
Sam Draper
Sam Draper () is Online Editor at WT | Wearable Technologies specialized in the field of sports and fitness but also passionated about any new lifestyle gadget on the market. Sam can be contacted at press(at)wearable-technologies.com.

RELATED ARTICLESMORE FROM AUTHOR